Cargando…

Tachycardia following Pfizer-BioNTech COVID-19 vaccine

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Martins-Filho, Paulo Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189116/ https://www.ncbi.nlm.nih.gov/pubmed/35721826 http://dx.doi.org/10.1016/j.eimc.2022.06.001

Ejemplares similares

Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Tachycardia following Pfizer-BioNTech COVID-19 vaccine”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022)

MRI Negative Myelitis Induced by Pfizer-BioNTech COVID-19 Vaccine
por: Cabral, Gonçalo, et al.
Publicado: (2022)

“Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine”: comment
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
por: Tanaka, Fumika, et al.
Publicado: (2021)

A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022)

Isolated Tachycardia Presenting After Pfizer-BioNTech COVID-19 Vaccination
por: Tate, Charles, et al.
Publicado: (2021)

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
por: D’Agati, Vivette D., et al.
Publicado: (2021)

Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: A case report
por: Delbarre, M., et al.
Publicado: (2022)

First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
por: Havla, Joachim, et al.
Publicado: (2021)

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
por: Tay, Carol, et al.
Publicado: (2022)

A case of membranous nephropathy following Pfizer–BioNTech mRNA vaccination against COVID-19
por: Da, Yi, et al.
Publicado: (2021)

Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)

Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)

Pfizer-BioNTech COVID-19 vaccine safe with clozapine
Publicado: (2022)

Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Lebedev, Larissa, et al.
Publicado: (2021)

Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination
por: Valenzuela, Daniel A., et al.
Publicado: (2021)

Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
por: Lim, Cho A, et al.
Publicado: (2022)

ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021)

Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
por: Zappa, Martina, et al.
Publicado: (2021)

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech)
por: Hamada, Yohhei
Publicado: (2021)

Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2) Vaccination
por: Cheng, Newman
Publicado: (2021)

Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine
por: Muhamad Fauzi, Siti Mardhiah
Publicado: (2023)

Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021)

Managing allergic reactions to Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Thyroiditis: case report
Publicado: (2021)

Pfizer-BioNtech's COVID-19 vaccine approved for younger adolescents
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine in patients with severe allergies
Publicado: (2021)

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021)

COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022)

COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report
Publicado: (2022)

No evidence of TTS risk with Pfizer/BioNTech's COVID-19 vaccine
Publicado: (2021)

Pfizer-BioNTech COVID-19 vaccine safe in older Koreans
Publicado: (2021)

Adverse reactions with Pfizer/BioNTech's COVID-19 vaccine in Ecuador
Publicado: (2021)

A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine
por: Yamada, Shunsuke, et al.
Publicado: (2022)

Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl
por: Bin Rubaian, Nouf F, et al.
Publicado: (2022)

Covid-19-vaccine-Pfizer-BioNTech: Vaccine failure: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2f1p7nqdd3prp8qd22cg2evo9t